key: cord-0826879-vn4qa3yc authors: Toto, Angelo; Ma, Sana; Malagrinò, Francesca; Visconti, Lorenzo; Pagano, Livia; Stromgaard, Kristian; Gianni, Stefano title: Comparing the binding properties of peptides mimicking the Envelope protein of SARS‐CoV and SARS‐CoV‐2 to the PDZ domain of the tight junction‐associated PALS1 protein date: 2020-08-21 journal: Protein Sci DOI: 10.1002/pro.3936 sha: ec4f83c4e5f37c6b0fd5227a9d42184c2008bb8b doc_id: 826879 cord_uid: vn4qa3yc The Envelope protein (E) is one of the four structural proteins encoded by the genome of SARS‐CoV and SARS‐CoV‐2 Coronaviruses. It is an integral membrane protein, highly expressed in the host cell, which is known to have an important role in Coronaviruses maturation, assembly and virulence. The E protein presents a PDZ‐binding motif at its C‐terminus. One of the key interactors of the E protein in the intracellular environment is the PDZ containing protein PALS1. This interaction is known to play a key role in the SARS‐CoV pathology and suspected to affect the integrity of the lung epithelia. In this paper we measured and compared the affinity of peptides mimicking the E protein from SARS‐CoV and SARS‐CoV‐2 for the PDZ domain of PALS1, through equilibrium and kinetic binding experiments. Our results support the hypothesis that the increased virulence of SARS‐CoV‐2 compared to SARS‐CoV may rely on the increased affinity of its Envelope protein for PALS1. This article is protected by copyright. All rights reserved. The recent spread of a novel coronavirus, SARS-CoV-2, causing coronavirus disease 2019 (COVID-19), represents a global health emergency of inconceivable severity, characterized by a remarkable morbidity and mortality worldwide. Coronaviruses are enveloped RNA viruses that causes respiratory, enteric, hepatic, and neurological diseases. SARS-CoV-2 is closely related to the original SARS-CoV, 1 the causal agent of the severe acute respiratory syndrome outbreaks in 2002 and 2003 in China. 2, 3 Because of the unprecedented impact of SARS-CoV-2 pandemic infection on world's economy and health systems, it is of critical importance to describe the main features related to its infectivity, diagnosis and prognosis. Furthermore, in an effort to establish the mechanisms of infection and propagation of SARS-CoV-2, it might be particularly useful to compare its behavior to that observed for SARS-CoV. A common pathogenic mechanism of different human viruses lies in their ability to hijack the cellular protein-protein interaction pathways. This feature is exerted by displaying short linear motifs, interacting with cellular proteins. Among these types of protein-protein recognition modules, PDZ domains represent a frequent target of viral systems, ranging from HPV, adenoviruses, rabies to influenza. 4, 5 These viruses display PDZ binding motifs (PBM) that bind specific cellular PDZ domain proteins, thereby jeopardizing the function of these proteins. In the case of SARS-CoV, a critical role has been suggested for the E protein, an integral membrane protein displaying a PBM in its C-terminus. 6, 7 In fact, a recombinant SARS-CoV virus lacking E results in an attenuated virulence in vivo. Moreover, a reduced virulence may also be obtained by removing exclusively the PBM of the E protein, 8 This article is protected by copyright. All rights reserved. role of the PDZ-dependent viral targeting of host proteins. The importance of E protein PBM was demonstrated in SARS-CoV infected cells, the deletion of the PBM resulting in the acquisition of an alternative PBM after several cell passages. 9 Among the cellular targets of the PBM of the E protein, it appears that PALS1 plays a pivotal role. 10 PALS1 is a PDZ containing polarity protein that is critical for the maintenance of epithelial polarity in mammals. The interaction between PALS1 and the E protein has been suggested to play a key role in the SARS-CoV pathology, by compromising the integrity of the lung epithelia and therefore dramatically increasing viral dissemination. 10, 11 Despite its importance, however, no study have successfully targeted t Despite the role of the PBM of the E protein has been already established, there is to date no quantitative information about its binding to PALS1. Furthermore, the differences, if any, between SARS-CoV and SARS-CoV-2 have not been studied in detail. The purpose of this study is therefore to provide a comparative quantitative assessment of these interactions. By comparing the binding equilibrium and kinetics of the PBM of SARS-CoV and SARS-CoV-2 on the PDZ domain of PALS1, we show here that the mutation in SARS-CoV-2 results in an increased affinity between the partners relative to SARS-CoV. In order to investigate the binding between the PDZ domain of PALS1 and the PBM of SARS-CoV and SARS-CoV-2, we synthesized two peptides mimicking their respective Ctermini ( Fig. 1) . A peptide search in Uniprot for the two sequences and confirmed that they are uniquely associated to the Envelope protein of Coronaviruses. Importantly, a recent investigation on 3617 naturally occurring mutants of Sars-CoV-2 have identified only 2 variants in SARS-CoV-2 falling in the PBM of the envelope protein. 12 Indeed, these mutations were suggested to mistarget the interaction to PALS1 and, accordingly, to reduce replication and/or infectivity of the virus. In analogy to our previous work on PDZ domains, 13 with excess concentrations of peptides and subjecting each solution to a rapid increase of temperature of 9°C, from 8 to 17°C, using a fluorescence equipped capacitor-discharge temperature-jump instrument. A typical fluorescence transition is reported in Figure 2 . A pseudo-first-order plot of the observed rate constants for the SARS-CoV and SARS-CoV-2 peptides is also reported in Figure 2 . In agreement with the equilibrium data, it is evident that the mutation results in an increase of the binding rate constant, as mirrored by the slopes of the observed dependence, and a decrease of the dissociation rate constant, which can be estimated from the extrapolation at zero peptide concentration. To further substantiate the This article is protected by copyright. All rights reserved. calculated values of the dissociation rate constants obtained from the analysis of the pseudofirst-order plots, we resorted to perform displacement experiments. 15 In particular, the preformed complex between the PDZ domain and each of the peptides was challenged with non-dansylated peptides, acting as competitive PBMs. At large excess of displacing reactant, approaching quasi-irreversibility (i.e. > ten times of the concentration of the complex), the measured dissociation rate constants were 520 ± 15 s -1 for the SARS-CoV complex and 350 ± 10 s -1 for the SARS-CoV-2 complex, confirming that the natural mutation occurring in the PBM of the E protein of SARS-CoV-2 corresponds to both an increase in association and decreased in dissociation rate constants respectively. Establishing the differences and similarities between SARS-CoV and SARS-CoV-2 from a biochemical perspective might be of vital importance to understand SARS-CoV-2 and to design specific drugs to fight its pathogenesis, as exemplified by the structural studies on the protein spike. 16, 17 Here we observe that SARS-CoV-2 displays an increased affinity for the PALS1, a binding event that appears to represent a critical step in compromising the lung epithelia and therefore in triggering viral infection. Indeed, whilst the interaction between PALS1 and the E protein has been already established as critical for the virulence of Sars-CoV, no successful inhibitors have been obtained to date. Our experimental observations support the hypothesis that characteristic virulence of SARS-CoV-2 could rely at least in part on the strengthened interaction between the E protein and PALS1. This article is protected by copyright. All rights reserved. Equilibrium binding titrations were performed on a Fluoromax single photon counting spectrofluorometer (Jobin-Yvon, NJ), by mixing a constant concentration of pseudo-wild-type PALS1 PDZ F318W (2μM) versus increasing concentrations of dansylated peptides mimicking SARS-CoV and SARS-CoV-2 Envelope proteins. Samples were excited at 280nm and fluorescence emission spectra were collected between 300nm and 400nm. Experiments were performed in buffer Sodium Phosphate 50mM pH 7.2 at 25°C. Relaxation binding experiments were performed using a Hi-Tech PTJ-64 capacitordischarge T-jump apparatus (Hi-Tech, Salisbury, U.K.). A constant concentration of pseudowild-type PALS1 PDZ F318W (10μM) was mixed with dansylated peptides mimicking SARS-CoV and SARS-CoV-2 Envelope proteins at different concentrations. Temperature was rapidly increased with a jump of ~9°C, from 8°C to 17°C. Samples were excited at 296nm and fluorescence was collected using a 320nm cut-off filter. Buffer used was Sodium Phosphate 50mM pH 7.2 in the presence of NaCl 150mM. Presence of NaCl in the buffer was required to ensure conductivity and temperature jump upon rapid discharge of the capacitor. Displacement experiments were performed using a single-mixing SX-18 stopped-flow instrument (Applied Photophysics, Leatherhead, Surrey, UK,). A preincubated complex of pseudo-wild-type PALS1 PDZ F318W (10μM) and dansylated peptides mimicking Envelope proteins (100μM for SARS-CoV and 50μM for SARS-CoV-2) were rapidly mixed with a high excess of non-dansylated peptide. The excitation wavelength was 280 nm, and emission was collected using a 475-nm cut-off glass filter. For each acquisition, the average of at least five independent experiments was fitted to a single exponential equation. The monitored reaction appears to be complete within ~4ms. Fluorescence emission before and after the temperature jump is shown (in gray). Black line represents the best fit to a single exponential function. A novel coronavirus from patients with pneumonia in China Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China A novel coronavirus associated with severe acute respiratory syndrome Viral targeting of PDZ polarity proteins in the immune system as a potential evasion mechanism PDZ proteins are expressed and regulated in antigenpresenting cells and are targets of influenza A virus Mechanisms and enzymes involved in SARS coronavirus genome expression Model of a putative pore: the pentameric alpha-helical bundle of SARS coronavirus E protein in lipid bilayers Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis Coronavirus virulence genes with main focus on SARS-CoV envelope gene SARS-CoV2 envelope protein: Nonsynonymous mutations and its consequences Ligand binding to the PDZ domains of postsynaptic density protein 95 Understanding the role of phosphorylation in the binding mechanism of a PDZ domain Hemoglobin and Myoglobin in Their Reactions with Ligands Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts